Hangzhou Sanofi Minsheng Health Pharmaceutical Co., Ltd. is a joint venture between Sanofi-Aventis and Hangzhou Minsheng Pharmaceutical Co., Ltd., one of the world famous pharmaceutical enterprises. Mainly engaged in OTC market sales. The joint venture will mainly produce and operate vitamin and mineral products. Vitamin and mineral products are the largest category in the OTC market in China, and Minsheng Pharmaceutical has gained considerable strength in this field with its flagship brand 2 1 Jinweita. Sanofi-Aventis is the fifth largest health pharmaceutical company in the world, and has continuously expanded its strength in the global health pharmaceutical field through mergers and acquisitions.